{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:01:02Z","timestamp":1778209262568,"version":"3.51.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.anai.2022.07.013","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T12:09:35Z","timestamp":1658405375000},"page":"552-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inborn errors of immunity associated with elevated immunoglobulin E"],"prefix":"10.1016","volume":"129","author":[{"given":"Yasmin W.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2318-6023","authenticated-orcid":false,"given":"Kelli W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 suppl 2","key":"10.1016\/j.anai.2022.07.013_bib0001","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaci.2013.08.037","article-title":"New childhood and adult reference intervals for total IgE","volume":"133","author":"Martins","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0003","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2009.06.011","article-title":"Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006","volume":"124","author":"Gergen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.013_bib0004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0091-6749(80)90026-3","article-title":"Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease","volume":"66","author":"Wittig","year":"1980","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000097025","article-title":"Reference values of total serum IgE and their significance in the diagnosis of allergy in young European adults","volume":"142","author":"Carosso","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/aap.2009.30.3193","article-title":"Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-a 10-year pediatric tertiary care center experience","volume":"30","author":"Joshi","year":"2009","journal-title":"Allergy Asthma Proc"},{"issue":"11","key":"10.1016\/j.anai.2022.07.013_bib0007","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/all.13578","article-title":"Hyper-IgE in the allergy clinic\u2013when is it primary immunodeficiency?","volume":"73","author":"Ponsford","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0008","first-page":"303","article-title":"Some aspects of immunity in patients with cystic fibrosis","volume":"18","author":"Wallwork","year":"1974","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaci.2008.10.023","article-title":"Primary immune deficiencies with aberrant IgE production","volume":"122","author":"Ozcan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2022.07.013_bib0010","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/humu.20408","article-title":"RAG-dependent primary immunodeficiencies","volume":"27","author":"Sobacchi","year":"2006","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0011","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imr.12701","article-title":"Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome","volume":"287","author":"Sullivan","year":"2019","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.anai.2022.07.013_bib0012","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/ajmg.a.38597","article-title":"Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome","volume":"176","author":"Crowley","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.anai.2022.07.013_bib0013","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/ajmg.a.38319","article-title":"The immune deficiency of chromosome 22q11.2 deletion syndrome","volume":"173","author":"Morsheimer","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0014","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10875-020-00854-y","article-title":"Relationship between severity of T cell lymphopenia and immune dysregulation in patients with DiGeorge syndrome (22q11.2 deletions and\/or related TBX1 mutations): a USIDNET study","volume":"41","author":"Deshpande","year":"2021","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3476(97)70199-9","article-title":"Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants","volume":"130","author":"Buckley","year":"1997","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0016","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(03)00104-3","article-title":"Genotype is an important determinant of phenotype in adenosine deaminase deficiency","volume":"15","author":"Hershfield","year":"2003","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.07.013_bib0017","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID) in the US Immunodeficiency Network (USIDNet) registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0018","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jaci.2013.05.040","article-title":"Elevated IgE and atopy in patients treated for early-onset ADA-SCID","volume":"132","author":"Lawrence","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.07.013_bib0019","series-title":"Stiehm's Immune Deficiencies: Inborn Errors of Immunity","year":"2020"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mpd.2001.115023","article-title":"Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency","volume":"139","author":"Rogers","year":"2001","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0021","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0022-3476(76)80793-7","article-title":"The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency","volume":"89","author":"Cederbaum","year":"1976","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.anai.2022.07.013_bib0022","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0023","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.anai.2022.07.013_bib0024","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.anai.2022.07.013_bib0025","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s004310100816","article-title":"Reviewing Omenn syndrome","volume":"160","author":"Aleman","year":"2001","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0026","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2008.09.037","article-title":"Omenn syndrome: inflammation in leaky severe combined immunodeficiency","volume":"122","author":"Villa","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1020550432126","article-title":"Omenn syndrome: a disorder of Rag1 and Rag2 genes","volume":"19","author":"Villa","year":"1999","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.013_bib0028","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.anai.2022.07.013_bib0029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0105-2896.2005.00231.x","article-title":"FOXP3 acts as a rheostat of the immune response","volume":"203","author":"Ochs","year":"2005","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jaci.2018.10.026","article-title":"Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency","volume":"142","author":"Cepika","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0031","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0032","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jmedgenet-2012-100759","article-title":"The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"49","author":"d'Hennezel","year":"2012","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0033","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","article-title":"Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity","volume":"122","author":"Gambineri","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0034","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anai.2022.07.013_bib0036","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.bi.64.070195.003201","article-title":"Transcriptional responses to polypeptide ligands: the JAK-STAT pathway","volume":"64","author":"Schindler","year":"1995","journal-title":"Annu Rev Biochem"},{"issue":"16","key":"10.1016\/j.anai.2022.07.013_bib0037","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.anai.2022.07.013_bib0038","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2013an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0039","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.iac.2018.08.007","article-title":"An update on syndromes with a hyper-IgE phenotype","volume":"39","author":"Bergerson","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"issue":"7157","key":"10.1016\/j.anai.2022.07.013_bib0040","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0041","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3476(98)70243-4","article-title":"The face of Job","volume":"133","author":"Borges","year":"1998","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.anai.2022.07.013_bib0042","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10875-017-0429-z","article-title":"Gastrointestinal manifestations of STAT3-deficient hyper-IgE syndrome","volume":"37","author":"Arora","year":"2017","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2022.07.013_bib0043","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bmt.1702446","article-title":"Bone marrow transplantation does not correct the hyper IgE syndrome","volume":"25","author":"Gennery","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0044","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9343(98)00200-9","article-title":"Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections","volume":"105","author":"Nester","year":"1998","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.anai.2022.07.013_bib0045","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0046","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.anai.2022.07.013_bib0047","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J Exp Med"},{"issue":"24","key":"10.1016\/j.anai.2022.07.013_bib0048","doi-asserted-by":"crossref","first-page":"eaat4956","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"B\u00e9ziat","year":"2018","journal-title":"Sci Immunol"},{"issue":"12","key":"10.1016\/j.anai.2022.07.013_bib0049","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2022.07.013_bib0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"5B deficiency: impacts on human growth and immunity","volume":"28","author":"STAT","year":"2016","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0051","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10875-015-0145-5","article-title":"Long-term follow-up of STAT5B deficiency in three Argentinian patients: clinical and immunological features","volume":"35","author":"Bezrodnik","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.anai.2022.07.013_bib0052","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2012.00234","article-title":"The STAT5b pathway defect and autoimmunity","volume":"3","author":"Kanai","year":"2012","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0053","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0054","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"issue":"195","key":"10.1016\/j.anai.2022.07.013_bib0055","doi-asserted-by":"crossref","first-page":"195ra194","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGF\u03b2 receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.anai.2022.07.013_bib0056","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.anai.2022.07.013_bib0057","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0058","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0059","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.jaci.2015.11.017","article-title":"Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients","volume":"137","author":"Happel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.det.2016.07.002","article-title":"Current status of dedicator of cytokinesis-associated immunodeficiency: DOCK8 and DOCK2","volume":"35","author":"Dimitrova","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.anai.2022.07.013_bib0061","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.3389\/fimmu.2018.02944","article-title":"A unique heterozygous CARD11 mutation combines pathogenic features of both gain- and loss-of-function patients in a four-generation family","volume":"9","author":"Desjardins","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0062","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jaci.2019.03.009","article-title":"Germline CBM-opathies: from immunodeficiency to atopy","volume":"143","author":"Lu","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.013_bib0063","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0064","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2018.09.002","article-title":"Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitis","volume":"143","author":"Peled","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0066","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.15010","article-title":"Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency","volume":"77","author":"Kolukisa","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2022.07.013_bib0067","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fimmu.2018.00203","article-title":"Novel CARMIL2 mutations in patients with variable clinical dermatitis, infections, and combined immunodeficiency","volume":"9","author":"Alazami","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0068","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOH.0b013e32834114bc","article-title":"Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome","volume":"18","author":"Albert","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"9","key":"10.1016\/j.anai.2022.07.013_bib0069","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1182\/blood-2012-08-448118","article-title":"Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome","volume":"121","author":"Mahlaoui","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.anai.2022.07.013_bib0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/TACG.S213920","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: updated perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.anai.2022.07.013_bib0071","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/TACG.S58444","article-title":"Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments","volume":"7","author":"Buchbinder","year":"2014","journal-title":"Appl Clin Genet"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0072","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10875-017-0453-z","article-title":"Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome","volume":"38","author":"Candotti","year":"2018","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0073","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190607","article-title":"Gene therapy for severe combined immunodeficiencies and beyond","volume":"217","author":"Fischer","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.anai.2022.07.013_bib0074","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3389\/fimmu.2018.02554","article-title":"The phenotype and treatment of WIP deficiency: literature synopsis and review of a patient with pre-transplant serial donor lymphocyte infusions to eliminate CMV","volume":"9","author":"Schwinger","year":"2018","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.anai.2022.07.013_bib0075","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1182\/blood-2018-07-863431","article-title":"T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency","volume":"132","author":"Brigida","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0076","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaci.2009.09.035","article-title":"Familial atypical cold urticaria: description of a new hereditary disease","volume":"124","author":"Gandhi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.07.013_bib0077","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0078","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10875-015-0177-x","article-title":"PLAID: a syndrome of complex patterns of disease and unique phenotypes","volume":"35","author":"Milner","year":"2015","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0079","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","article-title":"Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea","volume":"129","author":"Ma","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0080","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaip.2020.11.050","article-title":"JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease","volume":"9","author":"Eisenberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0081","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0082","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13023-018-0956-6","article-title":"Immune cell phenotype and functional defects in Netherton syndrome","volume":"13","author":"Eranko","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0083","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1525-1470.2008.00663.x","article-title":"Netherton syndrome and trichorrhexis invaginata\u2014a novel diagnostic approach","volume":"25","author":"Burk","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0084","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00441-013-1558-1","article-title":"Netherton syndrome: skin inflammation and allergy by loss of protease inhibition","volume":"351","author":"Hovnanian","year":"2013","journal-title":"Cell Tissue Res"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0085","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1111\/pde.12856","article-title":"Netherton syndrome mimicking pustular psoriasis: clinical implications and response to intravenous immunoglobulin","volume":"33","author":"Small","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"16","key":"10.1016\/j.anai.2022.07.013_bib0086","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1128\/MCB.00802-07","article-title":"Agm1\/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development","volume":"27","author":"Greig","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.anai.2022.07.013_bib0087","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0088","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.anai.2022.07.013_bib0089","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fped.2015.00054","article-title":"Glycans instructing immunity: the emerging role of altered glycosylation in clinical immunology","volume":"3","author":"Lyons","year":"2015","journal-title":"Front Pediatr"},{"key":"10.1016\/j.anai.2022.07.013_bib0090","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.723003","article-title":"PROLIDASE: a review from discovery to its role in health and disease","volume":"8","author":"Eni-Aganga","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.anai.2022.07.013_bib0091","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","article-title":"Monogenic lupus: it's all new!","volume":"49","author":"Costa-Reis","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0092","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/MPG.0000000000002402","article-title":"A novel manifestation of prolidase deficiency in a toddler diagnosed with very-early-onset Crohn disease","volume":"69","author":"Rizvi","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0093","first-page":"205","article-title":"Inflammatory bowel disease-like phenotype in a young girl with prolidase deficiency: a new spectrum of clinical manifestation","volume":"26","author":"Kuloglu","year":"2015","journal-title":"Genet Couns"},{"issue":"1","key":"10.1016\/j.anai.2022.07.013_bib0094","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13223-022-00658-2","article-title":"Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins","volume":"18","author":"Alrumayyan","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.07.013_bib0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2230.2006.02112.x","article-title":"A homozygous missense mutation in PEPD encoding peptidase D causes prolidase deficiency associated with hyper-IgE syndrome","volume":"31","author":"Hershkovitz","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.anai.2022.07.013_bib0096","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1034\/j.1399-3038.2002.00075.x","article-title":"Prolidase deficiency with hyperimmunoglobulin E: a case report","volume":"13","author":"Lopes","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"issue":"18","key":"10.1016\/j.anai.2022.07.013_bib0097","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1056\/NEJMoa0810719","article-title":"A homozygous CARD9 mutation in a family with susceptibility to fungal infections","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.anai.2022.07.013_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005293","article-title":"CARD9-dependent neutrophil recruitment protects against fungal invasion of the central nervous system","volume":"11","author":"Drummond","year":"2015","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0099","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jaci.2014.12.1930","article-title":"Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both","volume":"135","author":"Lanternier","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.07.013_bib0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10875-018-0539-2","article-title":"Inherited CARD9 deficiency: invasive disease caused by Ascomycete fungi in previously healthy children and adults","volume":"38","author":"Corvilain","year":"2018","journal-title":"J Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622005968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622005968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:29:58Z","timestamp":1761053398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622005968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1081120622005968"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.07.013","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn errors of immunity associated with elevated immunoglobulin E","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}